MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202637039593 A) filed by Celleron Therapeutics Limited on March 30, 2026, for Combination Of Cxd101 And An Il-15 Superagonist To Treat Proliferative Diseases Such As Cancer.
Inventors include La Thangue, Nicholas; and Barczak, Wojciech.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present invention provides a combination comprising N-(2-aminophenyl)-4-(1-[(1,3- dimethyl-1H-pyrazol-4-y1)methyl]piperidin-4-yl)benzamide (CXD101), or a pharmaceutically acceptable salt or solvate thereof, and an IL 15 superagonist, such as N-803. The combination is suitable for use in the treatment of proliferative disorders, such as cancer.
Disclaimer: Curated by HT Syndication.
